Free Trial

Outset Medical (OM) Competitors

Outset Medical logo
$13.35 -0.32 (-2.34%)
Closing price 08/19/2025 04:00 PM Eastern
Extended Trading
$13.34 -0.01 (-0.11%)
As of 08/19/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OM vs. INMD, IRMD, TNDM, KMTS, EMBC, SIBN, BBNX, AXGN, BVS, and SMLR

Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), Embecta (EMBC), SiBone (SIBN), Beta Bionics (BBNX), AxoGen (AXGN), Bioventus (BVS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Outset Medical vs. Its Competitors

Outset Medical (NASDAQ:OM) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

InMode has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$119.30M1.99-$127.98M-$20.29-0.66
InMode$394.82M2.27$181.27M$2.475.74

Outset Medical presently has a consensus price target of $24.67, suggesting a potential upside of 84.77%. InMode has a consensus price target of $18.04, suggesting a potential upside of 27.23%. Given Outset Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Outset Medical is more favorable than InMode.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

InMode has a net margin of 44.50% compared to Outset Medical's net margin of -82.06%. InMode's return on equity of 18.38% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-82.06% -97.17% -32.84%
InMode 44.50%18.38%16.35%

Outset Medical has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, InMode has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500.

68.0% of InMode shares are held by institutional investors. 2.4% of Outset Medical shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Outset Medical had 1 more articles in the media than InMode. MarketBeat recorded 5 mentions for Outset Medical and 4 mentions for InMode. InMode's average media sentiment score of 1.43 beat Outset Medical's score of 0.33 indicating that InMode is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
InMode
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

InMode beats Outset Medical on 11 of the 16 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OM vs. The Competition

MetricOutset MedicalMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$242.86M$2.09B$5.73B$9.79B
Dividend YieldN/AN/A4.54%4.09%
P/E Ratio-0.6636.6830.7225.12
Price / Sales1.999.73418.7096.88
Price / CashN/A51.2537.3459.16
Price / Book1.576.348.896.24
Net Income-$127.98M-$63.67M$3.26B$265.56M
7 Day Performance1.06%-0.99%-0.38%-1.76%
1 Month Performance-23.36%-0.04%3.54%0.61%
1 Year Performance50.82%28.72%28.53%20.84%

Outset Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OM
Outset Medical
1.5038 of 5 stars
$13.35
-2.3%
$24.67
+84.8%
+43.7%$242.86M$119.30M-0.66520Analyst Forecast
INMD
InMode
2.8226 of 5 stars
$13.80
-2.2%
$18.04
+30.7%
-11.6%$891.88M$394.82M5.59480Positive News
IRMD
iRadimed
4.5642 of 5 stars
$70.00
+0.1%
$72.00
+2.9%
+57.3%$889.51M$73.24M43.21110
TNDM
Tandem Diabetes Care
4.5726 of 5 stars
$10.11
-10.0%
$22.67
+124.2%
-76.2%$758.80M$940.20M-3.272,650
KMTS
Kestra Medical Technologies
N/A$14.65
+0.9%
$27.33
+86.6%
N/A$745.58M$59.81M0.00300
EMBC
Embecta
4.8 of 5 stars
$12.73
+3.7%
$19.00
+49.3%
-2.5%$717.67M$1.12B8.902,100High Trading Volume
SIBN
SiBone
4.3782 of 5 stars
$15.40
-1.8%
$23.67
+53.7%
+8.2%$676.45M$167.18M-27.50350
BBNX
Beta Bionics
2.8005 of 5 stars
$14.30
-3.0%
$22.56
+57.7%
N/A$640.75M$65.12M0.00294
AXGN
AxoGen
3.0664 of 5 stars
$14.01
+0.8%
$26.00
+85.6%
+25.3%$639.58M$187.34M-140.09450Short Interest ↑
BVS
Bioventus
3.0769 of 5 stars
$6.93
+0.1%
$13.75
+98.4%
-8.5%$569.26M$564.14M-11.361,200
SMLR
Semler Scientific
3.1821 of 5 stars
$35.28
-2.4%
$81.75
+131.7%
+11.2%$534.89M$56.29M14.52120

Related Companies and Tools


This page (NASDAQ:OM) was last updated on 8/20/2025 by MarketBeat.com Staff
From Our Partners